An integrated microfluidic chip for immunocapture, preconcentration and separation of ?-amyloid peptides
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25310%2F15%3A39900560" target="_blank" >RIV/00216275:25310/15:39900560 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1063/1.4931394" target="_blank" >http://dx.doi.org/10.1063/1.4931394</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1063/1.4931394" target="_blank" >10.1063/1.4931394</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
An integrated microfluidic chip for immunocapture, preconcentration and separation of ?-amyloid peptides
Popis výsledku v původním jazyce
We present an integrated microfluidic chip for detection of ?-amyloid (A?) peptides. A? peptides are major biomarkers for the diagnosis of Alzheimer's disease (AD) in its early stages. This microfluidic device consists of three main parts: (1) An immunocapture microcolumn based on self-assembled magnetic beads coated with antibodies specific to A? peptides, (2) a nano-porous membrane made of photopolymerized hydrogel for preconcentration, and (3) a microchip electrophoresis (MCE) channel with fluorescent detection. Sub-milliliter sample volume is either mixed off-chip with antibody coated magnetic beads and injected into the device or is injected into an already self-assembled column of magnetic beads in the microchannel. The captured peptides on the beads are then electrokinetically eluted and re-concentrated onto the nano-membrane in a few nano-liters. By integrating the nano-membrane, total assay time was reduced and also off-chip re-concentration or buffer exchange steps were not n
Název v anglickém jazyce
An integrated microfluidic chip for immunocapture, preconcentration and separation of ?-amyloid peptides
Popis výsledku anglicky
We present an integrated microfluidic chip for detection of ?-amyloid (A?) peptides. A? peptides are major biomarkers for the diagnosis of Alzheimer's disease (AD) in its early stages. This microfluidic device consists of three main parts: (1) An immunocapture microcolumn based on self-assembled magnetic beads coated with antibodies specific to A? peptides, (2) a nano-porous membrane made of photopolymerized hydrogel for preconcentration, and (3) a microchip electrophoresis (MCE) channel with fluorescent detection. Sub-milliliter sample volume is either mixed off-chip with antibody coated magnetic beads and injected into the device or is injected into an already self-assembled column of magnetic beads in the microchannel. The captured peptides on the beads are then electrokinetically eluted and re-concentrated onto the nano-membrane in a few nano-liters. By integrating the nano-membrane, total assay time was reduced and also off-chip re-concentration or buffer exchange steps were not n
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
CB - Analytická chemie, separace
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/7E12083" target="_blank" >7E12083: NAnosystems for the early DIagnosis of NEurodegenerative Diseases</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biomicrofluidics
ISSN
1932-1058
e-ISSN
—
Svazek periodika
9
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
8
Strana od-do
054117
Kód UT WoS článku
000364407300029
EID výsledku v databázi Scopus
—